BFC Planning’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
Other funds holding BLRX
BFC Planning's BLRX Position: Q3 2026 in Review
BFC Planning held its BioLineRX (BLRX) position steady in Q3 2026 at 28 shares worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #3404.
BFC Planning first reported a position in BLRX in Q2 2026 and has held it in 2 quarters since. The position peaked at $87 in Q2 2026. 12 funds tracked by Wall St. Rank hold BLRX as of Q3 2026.
- BFC Planning held 28 shares of BioLineRX worth $66 as of Q3 2026.
- BFC Planning left its BioLineRX share count unchanged in Q3 2026.
- BioLineRX made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3404 holding.
- BFC Planning first reported a position in BioLineRX in Q2 2026 and has held it in 2 quarters since.
- BFC Planning's BioLineRX position peaked at $87 in Q2 2026.
- 12 funds tracked by Wall St. Rank held BioLineRX as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.